Bausch + Lomb Corporation (BLCO)
Automate Your Wheel Strategy on BLCO
With Tiblio's Option Bot, you can configure your own wheel strategy including BLCO - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol BLCO
- Rev/Share 14.0486
- Book/Share 18.3512
- PB 0.8931
- Debt/Equity 0.7699
- CurrentRatio 1.5058
- ROIC 0.0064
- MktCap 5741416399.0
- FreeCF/Share -0.549
- PFCF -29.5238
- PE -18.8249
- Debt/Assets 0.3579
- DivYield 0
- ROE -0.0475
- Rating C+
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 4
- P/B Score 4
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | BLCO | Evercore ISI | Outperform | In-line | -- | $18 | Jan. 5, 2026 |
| Upgrade | BLCO | Citigroup | Neutral | Buy | -- | $20 | Dec. 11, 2025 |
| Upgrade | BLCO | Morgan Stanley | Equal Weight | Overweight | -- | $21 | Dec. 2, 2025 |
| Initiation | BLCO | Goldman | -- | Neutral | -- | $16 | Oct. 1, 2025 |
| Reiterated | BLCO | H.C. Wainwright | -- | Buy | $20 | $15 | May 2, 2025 |
| Downgrade | BLCO | Wells Fargo | Overweight | Equal Weight | $24 | $15 | March 28, 2025 |
| Downgrade | BLCO | Citigroup | Buy | Neutral | $24 | $22 | Dec. 11, 2024 |
| Upgrade | BLCO | Evercore ISI | In-line | Outperform | $19 | $25 | Oct. 15, 2024 |
News
BLCO vs. HQY: Which Stock Is the Better Value Option?
Published: January 23, 2026 by: Zacks Investment Research
Sentiment: Neutral
Investors looking for stocks in the Medical Services sector might want to consider either Bausch + Lomb (BLCO) or HealthEquity (HQY). But which of these two stocks is more attractive to value investors?
Read More
Bausch + Lomb Corporation (BLCO) Bausch + Lomb Corporation Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Published: December 03, 2025 by: Seeking Alpha
Sentiment: Neutral
Bausch + Lomb Corporation (BLCO) Bausch + Lomb Corporation Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Read More
Bausch + Lomb Corporation (BLCO) Bausch + Lomb Corporation - Analyst/Investor Day Transcript
Published: November 17, 2025 by: Seeking Alpha
Sentiment: Neutral
Bausch + Lomb Corporation ( BLCO ) Bausch + Lomb Corporation - Analyst/Investor Day November 13, 2025 8:30 AM EST Company Participants Brenton Saunders - CEO & Chairman of the Board Osama Eldessouky - Executive VP & CFO Yehia Hashad - Executive VP of Research & Development and Chief Medical officer John Ferris - President of Consumer Mayssa Attar Andrew Stewart - President of Global Pharmaceuticals & International Consumer Yang Yang - President of Vision Care Bryan Reed Luc Bonnefoy - President of Surgical Kelly Swaim Cathleen McCabe Eric Donnenfeld Mark Schaeffer Lejla Vajzovic Conference Call Participants William Trattler Lejla …
Read More
Bausch + Lomb Corporation (BLCO) Q3 2025 Earnings Call Transcript
Published: October 29, 2025 by: Seeking Alpha
Sentiment: Neutral
Bausch + Lomb Corporation ( BLCO ) Q3 2025 Earnings Call October 29, 2025 8:00 AM EDT Company Participants George Gadkowski Brenton L. Saunders - CEO & Chairman Osama Eldessouky - Executive VP & CFO Yehia Hashad - Executive VP of Research & Development and Chief Medical officer Conference Call Participants Patrick Wood - Morgan Stanley, Research Division Joanne Wuensch - Citigroup Inc., Research Division Young Li - Jefferies LLC, Research Division David Roman - Goldman Sachs Group, Inc., Research Division Lilia-Celine Lozada - JPMorgan Chase & Co, Research Division Pito Chickering - Deutsche Bank AG, Research Division Matthew Miksic …
Read More
Bausch + Lomb (BLCO) Q3 Earnings Beat Estimates
Published: October 29, 2025 by: Zacks Investment Research
Sentiment: Positive
Bausch + Lomb (BLCO) came out with quarterly earnings of $0.18 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.17 per share a year ago.
Read More
Bausch + Lomb Corporation (BLCO) Bausch + Lomb Corporation Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)
Published: September 08, 2025 by: Seeking Alpha
Sentiment: Neutral
Bausch + Lomb Corporation (NYSE:BLCO ) Bausch + Lomb Corporation Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 7:45 AM EDT Company Participants Brenton L. Saunders - CEO & Chairman Osama Eldessouky - Executive VP & CFO Conference Call Participants Patrick Wood - Morgan Stanley, Research Division Presentation Patrick Wood MD of Equity Research Good morning.
Read More
Bausch + Lomb (BLCO) Reports Q2 Earnings: What Key Metrics Have to Say
Published: July 30, 2025 by: Zacks Investment Research
Sentiment: Positive
Although the revenue and EPS for Bausch + Lomb (BLCO) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Read More
Bausch + Lomb (BLCO) Q2 Earnings and Revenues Surpass Estimates
Published: July 30, 2025 by: Zacks Investment Research
Sentiment: Positive
Bausch + Lomb (BLCO) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.13 per share a year ago.
Read More
New Strong Sell Stocks for July 30th
Published: July 30, 2025 by: Zacks Investment Research
Sentiment: Negative
ACHC, BLCO and BBCP have been added to the Zacks Rank #5 (Strong Sell) List on July 30, 2025.
Read More
Securities Fraud Investigation Into Bausch + Lomb Corporation (BLCO) Continues – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
Published: June 24, 2025 by: Business Wire
Sentiment: Neutral
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz continues its investigation of Bausch + Lomb Corporation (“BLCO” or the “Company”) (NYSE: BLCO) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON BAUSCH + LOMB CORPORATION (BLCO), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On March 27, 2025, BLCO disclosed that it had “[begun] to.
Read More
Bronstein, Gewirtz & Grossman, LLC Encourages Bausch + Lomb Corporation (BLCO) Stockholders to Inquire about Securities Investigation
Published: June 16, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / June 16, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Bausch + Lomb Corporation ("Bausch + Lomb" or "the Company") (NYSE:BLCO). Investors who purchased Bausch + Lomb securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/BLCO.
Read More
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Bausch + Lomb Corporation (BLCO) And Encourages Investors to Reach Out
Published: June 13, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / June 13, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Bausch + Lomb Corporation ("Bausch + Lomb" or "the Company") (NYSE:BLCO). Investors who purchased Bausch + Lomb securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/BLCO.
Read More
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Bausch + Lomb Corporation (BLCO) And Encourages Stockholders to Reach Out
Published: June 12, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / June 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Bausch + Lomb Corporation ("Bausch + Lomb" or "the Company") (NYSE:BLCO). Investors who purchased Bausch + Lomb securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/BLCO.
Read More
BLCO Investors Have Opportunity to Join Bausch + Lomb Corporation Fraud Investigation with the Schall Law Firm
Published: June 11, 2025 by: PRNewsWire
Sentiment: Neutral
LOS ANGELES , June 11, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Bausch + Lomb Corporation ("Bausch + Lomb" or "the Company") (NYSE: BLCO) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Read More
Bronstein, Gewirtz & Grossman, LLC Is Investigating Bausch + Lomb Corporation (BLCO) And Encourages Stockholders to Connect
Published: June 11, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / June 11, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Bausch + Lomb Corporation ("Bausch + Lomb" or "the Company") (NYSE:BLCO). Investors who purchased Bausch + Lomb securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/BLCO.
Read More
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Bausch + Lomb Corporation (BLCO) and Encourages Stockholders to Learn More About the Investigation
Published: June 09, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / June 9, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Bausch + Lomb Corporation ("Bausch + Lomb" or "the Company") (NYSE:BLCO). Investors who purchased Bausch + Lomb securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/BLCO.
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch + Lomb Corporation - BLCO
Published: June 06, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Bausch + Lomb Corporation (“Bausch + Lomb” or the “Company”) (NYSE: BLCO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch + Lomb Corporation - BLCO
Published: June 04, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / June 4, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Bausch + Lomb Corporation("Bausch + Lomb" or the "Company") (NYSE:BLCO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch + Lomb Corporation - BLCO
Published: June 02, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Bausch + Lomb Corporation (“Bausch + Lomb” or the “Company”) (NYSE: BLCO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch + Lomb Corporation - BLCO
Published: May 27, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / May 27, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Bausch + Lomb Corporation("Bausch + Lomb" or the "Company") (NYSE:BLCO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch + Lomb Corporation - BLCO
Published: May 22, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Bausch + Lomb Corporation (“Bausch + Lomb” or the “Company”) (NYSE: BLCO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch + Lomb Corporation - BLCO
Published: May 19, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / May 19, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Bausch + Lomb Corporation("Bausch + Lomb" or the "Company") (NYSE:BLCO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch + Lomb Corporation - BLCO
Published: May 16, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / May 16, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Bausch + Lomb Corporation("Bausch + Lomb" or the "Company") (NYSE:BLCO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch + Lomb Corporation - BLCO
Published: May 13, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Bausch + Lomb Corporation (“Bausch + Lomb” or the “Company”) (NYSE: BLCO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch + Lomb Corporation - BLCO
Published: May 09, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Bausch + Lomb Corporation (“Bausch + Lomb” or the “Company”) (NYSE: BLCO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Read More
Securities Fraud Investigation Into Bausch + Lomb Corporation (BLCO) Announced – Investors Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz
Published: May 07, 2025 by: Business Wire
Sentiment: Neutral
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Bausch + Lomb Corporation (“BLCO” or the “Company”) (NYSE: BLCO) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON BAUSCH + LOMB CORPORATION (BLCO), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is the Investigation About? On March 27, 2025, BLCO disclosed that it had “[begun] to.
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch + Lomb Corporation - BLCO
Published: May 07, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / May 7, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Bausch + Lomb Corporation("Bausch + Lomb" or the "Company") (NYSE:BLCO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch + Lomb Corporation - BLCO
Published: May 06, 2025 by: PRNewsWire
Sentiment: Neutral
NEW YORK , May 6, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Bausch + Lomb Corporation ("Bausch + Lomb" or the "Company") (NYSE: BLCO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch + Lomb Corporation - BLCO
Published: May 02, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / May 2, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Bausch + Lomb Corporation ("Bausch + Lomb" or the "Company") (NYSE:BLCO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch + Lomb Corporation - BLCO
Published: May 01, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / May 1, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Bausch + Lomb Corporation ("Bausch + Lomb" or the "Company") (NYSE:BLCO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Read More
About Bausch + Lomb Corporation (BLCO)
- IPO Date 2022-05-06
- Website https://www.bausch.com
- Industry Medical - Instruments & Supplies
- CEO Brenton L. Saunders
- Employees 13500